Literature DB >> 15689322

[The frequency of cancer in France in year 2000, and trends since 1950].

Catherine Hill1, Françoise Doyon.   

Abstract

In 2000, there were 87,000 cancer deaths among men and 57,000 cancer deaths among women in France. Cancer mortality is decreasing since 1987 in the male population and since the mid 1960s in the female population. The decrease is larger among men than among women. The estimated number of cancers diagnosed in 2000 is 160,000 in the male population and 120,000 in the female population. The most frequent cancer sites in the male population are prostate, lung, colon, intestine and mouth, pharynx plus larynx. In the female population, breast cancer is by far the most frequent cancer, followed by colorectal cancer. Between 1980 and 2000, cancer incidence increased by 30%, whereas cancer mortality decreased by 10%, these results are observed for each sex.

Entities:  

Mesh:

Year:  2005        PMID: 15689322

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  5 in total

1.  Is liver resection justified for patients with hepatic metastases from breast cancer?

Authors:  René Adam; Thomas Aloia; Jinane Krissat; Marie-Pierre Bralet; Bernard Paule; Sylvie Giacchetti; Valerie Delvart; Daniel Azoulay; Henri Bismuth; Denis Castaing
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

2.  Current status of adjuvant therapy for colon cancer.

Authors:  Thierry André; Pauline Afchain; Alain Barrier; Pierre Blanchard; Annette K Larsen; Christophe Tournigand; Christophe Louvet; Aimery de Gramont
Journal:  Gastrointest Cancer Res       Date:  2007-05

3.  Digestive cancers in Morocco: Fez-Boulemane region.

Authors:  Laila Chbani; Imane Hafid; Mohamed Berraho; Chakib Nejjari; Afaf Amarti
Journal:  Pan Afr Med J       Date:  2012-11-02

4.  Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: an observational study.

Authors:  Rupert Bartsch; Catharina Wenzel; Dagmar Hussian; Ursula Pluschnig; Ursula Sevelda; Wolfgang Koestler; Gabriela Altorjai; Gottfried J Locker; Robert Mader; Christoph C Zielinski; Guenther G Steger
Journal:  BMC Cancer       Date:  2006-03-15       Impact factor: 4.430

5.  Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.

Authors:  E Rouits; V Charasson; A Pétain; M Boisdron-Celle; J-P Delord; M Fonck; A Laurand; A-L Poirier; A Morel; E Chatelut; J Robert; E Gamelin
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.